Temozolomide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Temozolomide and local guidelines before prescribing.

Alkylating cytotoxic

Mechanism

Alkylating agent crossing the blood-brain barrier.

Uses

Glioblastoma, astrocytoma.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, fatigue, thrombocytopenia, neutropenia, constipation.

Interactions

Valproate raises levels.

Contraindications and cautions

Severe myelosuppression

Monitoring

FBC

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Caution in severe renal or hepatic impairment

Overdose and reversal

Supportive

Special advice

PJP prophylaxis with radiotherapy; weekly FBC during combined phase.

More from the textbook: uses, cautions and other points
Where it is discussed in the book